Dr. Roland Durner becomes new CEO of Bioengineering AG
Bioengineering AG announces that Dr. Roland Durner has taken over the position of Chief Executive Officer (CEO) as of July 1, 2024. He succeeds Marc Bachmann, who has accepted a new professional challenge after 6 years.

Dr. Roland Durner
Bioengineering AG
During his tenure, Marc Bachmann has actively shaped Bioengineering and contributed to the positive development of the company and its corporate culture. The Board of Directors would like to thank him for his commitment and valuable contributions and wishes him all the best for his future endeavors.
The Chairman of the Board of Directors, Marcus Bernhardt, adds: "With Dr. Roland Durner, Bioengineering AG welcomes an experienced and visionary manager to the role of CEO. He has extensive experience and has demonstrated his outstanding skills in various management positions both nationally and internationally in recent years".
The Board of Directors of Bioengineering AG is confident that Dr. Roland Durner, with his experience and strategic vision, is the right person to further develop the company and lead it into a promising future. We wish him a successful start and look forward to a substantive and productive collaboration.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

High-speed camera snaps bio-switch in action - X-ray experiment opens new route to study biochemical reactions

Rapid test for the determination of antibodies against Sars-Cov-2 - No elaborate biosafety precautions are necessary
Wageningen UR and Luminex develop multiplex detection for the agricultural and food industries

BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment - Development of a CRISPR-derived technology platform for cancer treatment
Monsanto and Evogene Extend Collaboration on Yield and Stress Research
Enzyme with high potential for new cancer treatment identified
Scientists uncover why major cow milk allergen is actually allergenic
